NDC 64764-155

Actoplus Met

Pioglitazone And Metformin Hydrochloride

Actoplus Met is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Pioglitazone Hydrochloride; Metformin Hydrochloride.

Product ID64764-155_3be0ae36-7d02-4416-9a6f-fb2d36d943b2
NDC64764-155
Product TypeHuman Prescription Drug
Proprietary NameActoplus Met
Generic NamePioglitazone And Metformin Hydrochloride
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2005-08-29
Marketing CategoryNDA / NDA
Application NumberNDA021842
Labeler NameTakeda Pharmaceuticals America, Inc.
Substance NamePIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE
Active Ingredient Strength15 mg/1; mg/1
Pharm ClassesPeroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Biguanide [EPC],Biguanides [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 64764-155-18

180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-155-18)
Marketing Start Date2005-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64764-155-60 [64764015560]

Actoplus Met TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021842
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-08-29

NDC 64764-155-41 [64764015541]

Actoplus Met TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021842
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-08-29

NDC 64764-155-18 [64764015518]

Actoplus Met TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021842
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-08-29

Drug Details

Active Ingredients

IngredientStrength
PIOGLITAZONE HYDROCHLORIDE15 mg/1

OpenFDA Data

SPL SET ID:42e49120-6f3f-11db-9fe1-0800200c9a66
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 861824
  • 861783
  • 861785
  • 861822
    • UPC Code
  • 0364764155605
  • 0364764158606

    • Pharmacological Class

    • Peroxisome Proliferator-activated Receptor Activity [MoA]
    • PPAR alpha [CS]
    • PPAR gamma [CS]
    • Thiazolidinedione [EPC]
    • Thiazolidinediones [CS]
    • Peroxisome Proliferator Receptor alpha Agonist [EPC]
    • Peroxisome Proliferator Receptor gamma Agonist [EPC]
    • Biguanide [EPC]
    • Biguanides [CS]

    Medicade Reported Pricing

    64764015560 ACTOPLUS MET 15 MG-500 MG TAB

    Pricing Unit: EA | Drug Type:

    64764015518 ACTOPLUS MET 15 MG-500 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Actoplus Met" or generic name "Pioglitazone And Metformin Hydrochloride"

    NDCBrand NameGeneric Name
    64764-155Actoplus Metpioglitazone and metformin hydrochloride
    64764-158Actoplus Metpioglitazone and metformin hydrochloride
    64764-310Actoplus Metpioglitazone and metformin hydrochloride
    64764-510Actoplus Metpioglitazone and metformin hydrochloride
    0093-7677Pioglitazone and Metformin HydrochloridePioglitazone and Metformin Hydrochloride
    0093-7678Pioglitazone and Metformin HydrochloridePioglitazone and Metformin Hydrochloride
    42291-512Pioglitazone and Metformin HydrochloridePioglitazone and Metformin Hydrochloride
    42291-513Pioglitazone and Metformin HydrochloridePioglitazone and Metformin Hydrochloride

    Trademark Results [Actoplus Met]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ACTOPLUS MET
    ACTOPLUS MET
    78218773 3149378 Live/Registered
    TAKEDA PHARMACEUTICAL COMPANY LIMITED
    2003-02-25
    ACTOPLUS MET
    ACTOPLUS MET
    78174989 not registered Dead/Abandoned
    Takeda Chemical Industries, Ltd.
    2002-10-16
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.